| URL | https://www.fiercepharma.com/manufacturing/35m-inv |
| Source | Fierce Pharma |
| Date Published | 08/19/2021 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Curia |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2021 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 35 |
| City reshored to: | Rensselaer |
| State(s) reshored to: | NY |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | high-potency API |